LIGAND PHARMACEUTICALS INC ($LGND)
Filing Information
| Accession Number | 0001104659-26-023943 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 5, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
6,102
Total Value
$551,234.34
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Mar 3, 2026 | Exercise/Conversion | 2,034 | $69.51 | $141,383.34 | 35,827 | Direct | โ | View Details | |
Director | Common Stock | โ | Mar 3, 2026 | Sale | 2,034 | $201.50 | $409,851.00 | 33,793 | Direct | โ | View Details | |
Director | Non- Qualified Stock Option (right to buy) | Derivative | Mar 3, 2026 | Exercise/Conversion | 2,034 | $0.00 | $0.00 | 0 | Direct | โ | View Details |